<DOC>
	<DOCNO>NCT00422461</DOCNO>
	<brief_summary>The purpose study evaluate safety blood pressure lower effect different dos PF-00489791 patient mild moderate high blood pressure</brief_summary>
	<brief_title>A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Males and/or Females nonchildbearing potential 18 70 year age 2 . History mild moderate hypertension 1 . Type 1 2 diabetes prescribe medication 2 . Secondary , severe , malignant hypertension 3 . History significant cardiovascular event within last 12 month enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Clinical Trial , Randomized Controlled Trial , Humans , Cyclic Nucleotide Phosphodiesterases Type 5</keyword>
</DOC>